SCHEMBL19784066

SCHEMBL19784066

NCc1ccc(-c2cccc(C(C(=O)OCC3CCN(Cc4ccccc4)CC3)c3ccccc3)c2)s1

nearest known ligand 0.46

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 2/20 0.46
ACHE P22303 5/20 0.45
BCHE P06276 3/20 0.45
MAOB P27338 1/20 0.45
DRD2 P14416 3/20 0.44
DRD4 P21917 3/20 0.44
ADRB2 P07550 1/20 0.40
CYP2E1 P05181 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2A6 P11509 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2B6 P20813 1/20 0.40
CYP2C19 P33261 1/20 0.40
ACKR3 P25106 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19782471 0.94 ACHE (0.48) CHRM3ACHEBCHEMAOBDRD2
SCHEMBL22839814 0.89 ACHE (0.46) CHRM3ACHEBCHEMAOBDRD2
SCHEMBL22839858 0.88 CHRM3 (0.45) CHRM3ACHEBCHEMAOBDRD2
SCHEMBL19782636 0.82 CHRM3 (0.68) CHRM3ACHEBCHEMAOBDRD2
SCHEMBL19770172 0.82 CHRM3 (0.68) CHRM3ACHEBCHEMAOBDRD2
SCHEMBL22839807 0.82 ACHE (0.42) CHRM3ACHEBCHEDRD2DRD4
SCHEMBL19782568 0.81 ACHE (0.47) CHRM3ACHEBCHEMAOBDRD2
SCHEMBL19770158 0.80 CHRM3 (0.70) CHRM3ACHEBCHEMAOBDRD2
SCHEMBL19770163 0.80 CHRM3 (0.70) CHRM3ACHEBCHEMAOBDRD2
SCHEMBL19782287 0.80 CHRM3 (0.70) CHRM3ACHEBCHEMAOBDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3484879-B1 HYDROXYQUINOLINONE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY CHIESI FARM SPA (IT) 2020-12-30 EP disclosed
WO-2018011090-A1 HYDROXYQUINOLINONE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY CHIESI FARMACEUTICI S.P.A. (IT) 2018-01-18 WO disclosed